Ann Surg Oncol5 Jan 2024
The study analyzed the efficacy of neoadjuvant chemoradiation therapy (ncrt) in patients with completely resectable esophageal squamous cell carcinoma (escc) and minimal lymph node involvement (cN1). The researchers conducted a retrospective review of 247 patients who underwent upfront radical esophagectomy followed by adjuvant treatment. They…
Ann Surg Oncol5 Jan 2024
The study compared postoperative complications between neoadjuvant chemotherapy and upfront surgery in gastric adenocarcinoma patients in Finland. Analyzing data from 769 patients, the study found that neoadjuvant chemotherapy did not increase major postoperative complications, including pneumonia, anastomotic complications, wound complications, or other complications. The results…
JAMA Surg4 Jan 2024
The study developed and validated a procedure-specific competency assessment tool (CAT) for minimally invasive esophagectomy (MIE). The CAT consists of 8 procedural phases, with 4 quality components per phase, assessed using a 1-4 Likert scale. Peer-reviewed MIE videos were evaluated by 18 international experts. Results…
Surg Endosc4 Jan 2024
Researchers conducted an international Delphi consensus study to determine expert agreement on the key technical steps of minimally invasive total gastrectomy (MITG) for gastric cancer. A final consensus of 41 statements was reached, outlining crucial steps for performing high-quality MITG for oncological indications. The findings…
Surg Obes Relat Dis4 Jan 2024
Symptomatic hiatal hernia (HH) with pouch migration is a rare complication after laparoscopic Roux-en-Y gastric bypass (RYGB), and there is limited evidence on the utility of surgical repair. In this retrospective review of 44 patients who underwent isolated HH repair after previous RYGB, researchers found…
Surg Today4 Jan 2024
Long-term tube feeding intervention after minimally invasive esophagectomy was found to effectively prevent skeletal muscle loss and aid in preventing sarcopenia. The study compared short-term and long-term outcomes of tube feeding intervention in patients who underwent esophagectomy. While there were no significant differences in postoperative…
Eur J Surg Oncol3 Jan 2024
Comparative study between two tertiary centers in Europe reveals that the time interval from diagnosis to treatment differs significantly between the centers. The main reasons for these differences are the need for additional diagnostics and variations in referral routines. Gastroscopy was frequently repeated for further…
Langenbecks Arch Surg3 Jan 2024
The study compared the efficacy and efficiency of laparoscopic transverse abdominis plane block (lap-tap) versus ultrasound-guided tap (us-tap) in patients undergoing pancreatoduodenectomy and gastrectomy. The lap-tap group showed a significantly shorter median time to skin incision and a reduction in operation cost by $602 compared…
Ann Surg Oncol2 Jan 2024
Results from a propensity score-matching study comparing robotic gastrectomy (RG) and laparoscopic gastrectomy (LG) revealed that RG is safe and feasible for elderly patients with advanced gastric cancer. The study found that RG was associated with less intraoperative blood loss, a faster postoperative recovery time,…
Ann Surg Oncol1 Jan 2024
Neoadjuvant docetaxel-based chemotherapy followed by en bloc resection is an effective treatment for locally advanced esophageal adenocarcinoma. Results from a 15-year retrospective analysis showed that both docetaxel/cisplatin/5FU and 5FU/leucovorin/oxaliplatin/docetaxel regimens achieved similar survival outcomes. A high percentage of patients completed the neoadjuvant cycles, and the…